Strontium ranelate reduces the risk of vertebral fracture in young postmenopausal women with severe osteoporosis.

Early osteoporotic fractures have a great impact on disease progression, the first fracture being a major risk factor for further fractures. Strontium ranelate efficacy against vertebral fractures is presently assessed in a subset of women aged 50-65 years